Metadherin regulates metastasis of squamous cell carcinoma of the head and neck via AKT signalling pathway-mediated epithelial-mesenchymal transition

Cancer Letters

Volumn 343, Issue 2, 2014, Pages 258-267

  Yu, Changyun ^a,b   Liu, Yong ^a,b   Tan, Haolei ^a,b   Li, Guo ^a,b   Su, Zhongwu ^a,b   Ren, Shuling ^a,b   Zhu, Gangcai ^a,b   Tian, Yongquan ^a,b   Qiu, Yuanzheng ^a,b   Zhang, Xin ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Otolaryngology Major Disease Research Key Laboratory of Hunan Province   (China)

Author keywords

AKT; Epithelial mesenchymal transition; Metadherin; Metastasis; Squamous cell carcinoma of the head and neck

Indexed keywords

PROTEIN KINASE B; UVOMORULIN; VIMENTIN;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER PROGNOSIS; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

AKT; EPITHELIAL-MESENCHYMAL TRANSITION; METADHERIN; METASTASIS; SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL ADHESION MOLECULES; CELL LINE, TUMOR; DISEASE-FREE SURVIVAL; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 84891826772     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.09.033     Document Type: Article

References (40)

1. Leemans C.R., Braakhuis B.J., Brakenhoff R.H. The molecular biology of head and neck cancer. Nat. Rev. Cancer 2011, 11:9-22.
2. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics. CA Cancer J. Clin. 2002, 55(2005):74-108.
3. Kamangar F., Dores G.M., Anderson W.F. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J. Clin. Oncol. 2006, 24:2137-2150.
4. Bhave S.L., Teknos T.N., Pan Q. Molecular parameters of head and neck cancer metastasis. Crit. Rev. Eukaryot. Gene Expr. 2011, 21:143-153.
5. Gomes L.R., Terra L.F., Sogayar M.C., Labriola L. Epithelial-mesenchymal transition: implications in cancer progression and metastasis. Curr. Pharm. Biotechnol. 2011, 12:1881-1890.
6. Savagner P. The epithelial-mesenchymal transition (EMT) phenomenon. Ann. Oncol. 2010, 21(Suppl 7):vii89-vii92.
7. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2002, 2:442-454.
8. Thiery J.P. Epithelial-mesenchymal transitions in development and pathologies. Curr. Opin. Cell Biol. 2003, 15:740-746.
9. Huber M.A., Kraut N., Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr. Opin. Cell Biol. 2005, 17:548-558.
10. Lim J., Thiery J.P. Epithelial-mesenchymal transitions: insights from development. Development 2012, 139:3471-3486.
11. Mandal M., Myers J.N., Lippman S.M., Johnson F.M., Williams M.D., Rayala S., Ohshiro K., Rosenthal D.I., Weber R.S., Gallick G.E., El-Naggar A.K. Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features. Cancer 2008, 112:2088-2100.
12. Jouppila-Matto A., Narkio-Makela M., Soini Y., Pukkila M., Sironen R., Tuhkanen H., Mannermaa A., Kosma V.M. Twist and snai1 expression in pharyngeal squamous cell carcinoma stroma is related to cancer progression. BMC Cancer 2011, 11:350.
13. Scanlon C.S., Van Tubergen E.A., Inglehart R.C., D'Silva N.J. Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma. J. Dent. Res. 2013, 92:114-121.
14. Liu H., Song X., Liu C., Xie L., Wei L., Sun R. Knockdown of astrocyte elevated gene-1 inhibits proliferation and enhancing chemo-sensitivity to cisplatin or doxorubicin in neuroblastoma cells. J. Exp. Clin. Cancer Res. 2009, 28:19.
15. He X.X., Chang Y., Meng F.Y., Wang M.Y., Xie Q.H., Tang F., Li P.Y., Song Y.H., Lin J.S. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene 2012, 31:3357-3369.
16. Emdad L., Lee S., Su Z.Z., Jeon H.Y., Boukerche H., Sarkar D., Fisher P.B. Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:21300-21305.
17. Li C., Li R., Song H., Wang D., Feng T., Yu X., Zhao Y., Liu J., Yu X., Wang Y., Geng J. Significance of AEG-1 expression in correlation with VEGF, microvessel density and clinicopathological characteristics in triple-negative breast cancer. J. Surg. Oncol. 2011, 103:184-192.
18. Emdad L., Sarkar D., Su Z.Z., Randolph A., Boukerche H., Valerie K., Fisher P.B. Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis. Cancer Res. 2006, 66:1509-1516.
19. Yoo B.K., Gredler R., Vozhilla N., Su Z.Z., Chen D., Forcier T., Shah K., Saxena U., Hansen U., Fisher P.B., Sarkar D. Identification of genes conferring resistance to 5-fluorouracil. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:12938-12943.
20. Li J., Zhang N., Song L.B., Liao W.T., Jiang L.L., Gong L.Y., Wu J., Yuan J., Zhang H.Z., Zeng M.S., Li M. Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clin. Cancer Res. 2008, 14:3319-3326.
21. Noch E., Bookland M., Khalili K. Astrocyte-elevated gene-1 (AEG-1) induction by hypoxia and glucose deprivation in glioblastoma. Cancer Biol. Ther. 2011, 11:32-39.
22. Jian-bo X., Hui W., Yu-long H., Chang-hua Z., Long-juan Z., Shi-rong C., Wen-hua Z. Astrocyte-elevated gene-1 overexpression is associated with poor prognosis in gastric cancer. Med. Oncol. 2011, 28:455-462.
23. Kikuno N., Shiina H., Urakami S., Kawamoto K., Hirata H., Tanaka Y., Place R.F., Pookot D., Majid S., Igawa M., Dahiya R. Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity. Oncogene 2007, 26:7647-7655.
24. Li X., Kong X., Huo Q., Guo H., Yan S., Yuan C., Moran M.S., Shao C., Yang Q. Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transition. Cancer Sci. 2011, 102:1151-1157.
25. Zhu K., Dai Z., Pan Q., Wang Z., Yang G.H., Yu L., Ding Z.B., Shi G.M., Ke A.W., Yang X.R., Tao Z.H., Zhao Y.M., Qin Y., Zeng H.Y., Tang Z.Y., Fan J., Zhou J. Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin. Cancer Res. 2011, 17:7294-7302.
26. Liu Y., Su Z., Li G., Yu C., Ren S., Huang D., Fan S., Tian Y., Zhang X., Qiu Y. Increased expression of metadherin protein predicts worse disease-free and overall survival in laryngeal squamous cell carcinoma. Int. J. Cancer 2013, 133:671-679.
27. Sacks P.G. Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck. Cancer Metastasis Rev. 1996, 15:27-51.
28. Yu C., Liu Y., Huang D., Dai Y., Cai G., Sun J., Xu T., Tian Y., Zhang X. TGF-beta1 mediates epithelial to mesenchymal transition via the TGF-beta/Smad pathway in squamous cell carcinoma of the head and neck. Oncol. Rep. 2011, 25:1581-1587.
29. Liu Y., Yu C., Qiu Y., Huang D., Zhou X., Zhang X., Tian Y. Downregulation of EphA2 expression suppresses the growth and metastasis in squamous-cell carcinoma of the head and neck in vitro and in vivo. J. Cancer Res. Clin. Oncol. 2012, 138:195-202.
30. Zhang X., Liu Y., Gilcrease M.Z., Yuan X.H., Clayman G.L., Adler-Storthz K., Chen Z. A lymph node metastatic mouse model reveals alterations of metastasis-related gene expression in metastatic human oral carcinoma sublines selected from a poorly metastatic parental cell line. Cancer 2002, 95:1663-1672.
31. Sarkar D., Emdad L., Lee S.G., Yoo B.K., Su Z.Z., Fisher P.B. Astrocyte elevated gene-1: far more than just a gene regulated in astrocytes. Cancer Res. 2009, 69:8529-8535.
32. Kang D.C., Su Z.Z., Sarkar D., Emdad L., Volsky D.J., Fisher P.B. Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. Gene 2005, 353:8-15.
33. Yoo B.K., Emdad L., Su Z.Z., Villanueva A., Chiang D.Y., Mukhopadhyay N.D., Mills A.S., Waxman S., Fisher R.A., Llovet J.M., Fisher P.B., Sarkar D. Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J. Clin. Invest. 2009, 119:465-477.
34. Lee S.G., Jeon H.Y., Su Z.Z., Richards J.E., Vozhilla N., Sarkar D., Van Maerken T., Fisher P.B. Astrocyte elevated gene-1 contributes to the pathogenesis of neuroblastoma. Oncogene 2009, 28:2476-2484.
35. Song L., Li W., Zhang H., Liao W., Dai T., Yu C., Ding X., Zhang L., Li J. Over-expression of AEG-1 significantly associates with tumour aggressiveness and poor prognosis in human non-small cell lung cancer. J. Pathol. 2009, 219:317-326.
36. Lee S.G., Su Z.Z., Emdad L., Sarkar D., Fisher P.B. Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:17390-17395.
37. Lee S.G., Su Z.Z., Emdad L., Sarkar D., Franke T.F., Fisher P.B. Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling. Oncogene 2008, 27:1114-1121.
38. Emdad L., Lee S.G., Su Z.Z., Jeon H.Y., Boukerche H., Sarkar D., Fisher P.B. Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:21300-21305.
39. Johann D.J., McGuigan M.D., Patel A.R., Tomov S., Ross S., Conrads T.P., Veenstra T.D., Fishman D.A., Whiteley G.R., Petricoin E.R., Liotta L.A. Clinical proteomics and biomarker discovery. Ann. N.Y. Acad. Sci. 2004, 1022:295-305.
40. Zhao Z., Ge J., Sun Y., Tian L., Lu J., Liu M., Zhao Y. Is E-cadherin immunoexpression a prognostic factor for head and neck squamous cell carcinoma (HNSCC)? A systematic review and meta-analysis. Oral Oncol. 2012, 48:761-767.